Skip to main content
Completed Clinical Trials

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Advanced Malignant Mesothelioma|Recurrent Malignant Mesothelioma

Estimated Enrollment: 39

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: NCI-2009-00693|CDR0000652058|NCIC-183

Study First Received: October 25, 2006

Last Updated: May 5, 2014

Estimated Primary Completion Date: January 2012

 

Primary Outcome Measures:

Objective Response (Partial and Complete) Per RECIST

Sponsors and Collaborators:

National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00392444

Leave a Reply